Results for "Specialty Pharmaceutical Distribution Facts, Figures, and Trends"
HDA Statement on FDA's Proposed National Standards for Licensure of Distributors and 3PLs
The Healthcare Distribution Alliance (HDA) released the following statement on the U.S. Food and Drug Administration’s (FDA) proposed national licensure standards for distributors and third-party logistics providers (3PLs). HDA recently submitted public comments to FDA on the agency’s proposed standards, which are required to be established under the 2013 Drug Supply Chain Security Act (DSCSA).
HDA Appoints Kala Shankle Vice President of Regulatory Affairs
HDA announces the appointment of Kala Shankle as Vice President of Regulatory Affairs.